Compound Access
Psilocybin
Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research.
Country GuideMedical AccessOff-label Medical
Country Access Report
Medical Access in Argentina
Argentina has an established regulatory framework for specific psychedelic derivatives, specifically Esketamine, while maintaining strict prohibition for classic hallucinogens like Psilocybin and MDMA.
- Access Level
- Off-label Medical
- Compounds Covered
- 3
- Active Trials
- 1
How To Use This Guide
Read the access level as a starting point, then check the compound notes below. The practical question is whether a patient can move through a real pathway today, or whether access still depends on a trial, exception route, private-care model, or future reimbursement decision.
Available Today
Look for approved use, named specialist settings, eligibility rules, and whether care is routine or exceptional.
Research Or Exception
Separate clinical trials, special access, compassionate use, and unlicensed-medicine routes from routine medical availability.
Payment And Delivery
Check who pays, where care can happen, and whether trained teams, product supply, and site governance are in place.
Access By Compound
These notes separate what is available today from research, exceptional-access, private-care, and payment routes. When the guide has not verified a pathway, the compound stays marked as incomplete rather than treated as unavailable.
Strictly Illegal
Compound Access
Esketamine
Spravato (esketamine nasal spray) was approved by the National Administration of Medicines, Food and Medical Technology (ANMAT) in April 2021 for treatment-resistant depression [1]. Coverage is currently primarily through private health insurance (prepagas) and specific medical exceptions.
Compound Access
Ketamine
Ketamine is strictly regulated and authorized for anesthetic and analgesic use in hospital settings. Off-label use for psychiatric conditions is emerging in private clinics but is not standardly reimbursed.
Sources and Review
Last updated 2 Mar 2026. Source links come from the medical access guide.